Loading
Every connected record, the notes, the JSON, Markdown and RDF twins, and where the record came from and when it was checked.
Direct links plus the targets, companies, and technologies of this cancer's products.
Shares Bruno Sangro, N4BP2, Virogin Biotech, Molecularly guided therapies for advanced primary liver cancers refractory to systemic treatment: results from the 2025 French genomic medicine initiative and the tag gi.
Shares AZD4360, A Study of MT-4561 in Patients With Various Advanced Solid Tumors, A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors, Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors and the tag gi.
Shares A Study of MT-4561 in Patients With Various Advanced Solid Tumors, Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors, RNF213, Clinical colorectal cancer and the tag gi.
Shares TiumBio, A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors, ANK1, A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors and the tag gi.
Shares Obstructive jaundice and biliary obstruction, CA 19-9, Endoscopic ultrasound and EBUS systems, MRI and the tag gi.
Shares Obstructive jaundice and biliary obstruction, Endoscopic ultrasound and EBUS systems, Pancreatic ductal adenocarcinoma and the tag gi.
Shares Obstructive jaundice and biliary obstruction, Whipple procedure (pancreaticoduodenectomy), Pancreatic ductal adenocarcinoma and the tag gi.
Shares KRAS wild-type pancreatic ductal adenocarcinoma, Comprehensive genomic profiling, Pancreatic ductal adenocarcinoma and the tag gi.
The same record for scripts and assistants; checked 2026-09-04. Data CC BY-NC 4.0, attribute “Data from OnCo (onco.cc)”.